Claybrook Capital’s Sanofi SNY Stock Holding History

Claybrook Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-704	Closed	-$31K	–	598
2018 Q4	$31K	Buy	+704	New	+$31K	0.01%	302

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Claybrook Capital's SNY Position: Q1 2019 in Review

Claybrook Capital sold out of Sanofi (SNY) in Q1 2019, closing a stake of 704 shares — an estimated $31K sold.

Claybrook Capital first reported a position in SNY in Q4 2018 and held it in 1 quarter. The position peaked at $31K in Q4 2018. 489 funds tracked by Wall St. Rank hold SNY as of Q1 2019.

Claybrook Capital reported no remaining Sanofi position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 704 Sanofi shares in Q1 2019, an estimated $31K.
Claybrook Capital first reported a position in Sanofi in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Sanofi position peaked at $31K in Q4 2018.
489 funds tracked by Wall St. Rank held Sanofi as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.